COVID-19 and the cardiovascular system: a study of pathophysiology and interpopulation variability

Y Zhao, X Han, C Li, Y Liu, J Cheng… - Frontiers in …, 2023 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in humans
can lead to various degrees of tissue and organ damage, of which cardiovascular system …

COVID-19 with stress cardiomyopathy mortality and outcomes among patients hospitalized in the United States: a propensity matched analysis using the national …

MG Davis, A Bobba, H Majeed, MI Bilal… - Current Problems in …, 2023 - Elsevier
Takotsubo syndrome (stress cardiomyopathy) has become a well-known complication of
COVID-19 infections, with limited large-scale studies evaluating outcomes. We used the …

Nationwide analysis of the outcomes and mortality of hospitalized infants with concomitant diagnosis of COVID-19

P Krishnan, A Malik, A Isath… - American Journal of …, 2024 - thieme-connect.com
Objective Coronavirus disease 2019 (COVID-19) generally causes milder illness in the
pediatric population. However, infants represent a higher-risk population with evolving …

Pathogenic mechanisms of cardiovascular damage in COVID-19

HH Shao, RX Yin - Molecular Medicine, 2024 - Springer
Background COVID-19 is a new infectious disease caused by the severe acute respiratory
syndrome coronavirus 2 (SARS CoV-2). Since the outbreak in December 2019, it has …

Bioinformatics and system biology analysis revealed the crosstalk between COVID‐19 and osteoarthritis

B Lai, H Jiang, T Liao, Y Gao… - … Inflammation and Disease, 2023 - Wiley Online Library
Background The global coronavirus disease 2019 (COVID‐19) outbreak has significantly
impacted public health. Moreover, there has been an association between the incidence …